1. Home
  2. LGND vs OLN Comparison

LGND vs OLN Comparison

Compare LGND & OLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • OLN
  • Stock Information
  • Founded
  • LGND 1987
  • OLN 1892
  • Country
  • LGND United States
  • OLN United States
  • Employees
  • LGND N/A
  • OLN N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • OLN Major Chemicals
  • Sector
  • LGND Health Care
  • OLN Industrials
  • Exchange
  • LGND Nasdaq
  • OLN Nasdaq
  • Market Cap
  • LGND 2.0B
  • OLN 2.4B
  • IPO Year
  • LGND 1992
  • OLN N/A
  • Fundamental
  • Price
  • LGND $102.19
  • OLN $19.40
  • Analyst Decision
  • LGND Strong Buy
  • OLN Hold
  • Analyst Count
  • LGND 8
  • OLN 15
  • Target Price
  • LGND $144.71
  • OLN $29.27
  • AVG Volume (30 Days)
  • LGND 118.3K
  • OLN 1.8M
  • Earning Date
  • LGND 05-08-2025
  • OLN 07-24-2025
  • Dividend Yield
  • LGND N/A
  • OLN 4.12%
  • EPS Growth
  • LGND N/A
  • OLN N/A
  • EPS
  • LGND N/A
  • OLN 0.52
  • Revenue
  • LGND $181,488,000.00
  • OLN $6,549,000,000.00
  • Revenue This Year
  • LGND $17.68
  • OLN $2.89
  • Revenue Next Year
  • LGND $18.69
  • OLN $4.86
  • P/E Ratio
  • LGND N/A
  • OLN $37.51
  • Revenue Growth
  • LGND 53.40
  • OLN N/A
  • 52 Week Low
  • LGND $77.43
  • OLN $17.66
  • 52 Week High
  • LGND $129.90
  • OLN $54.05
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • OLN 39.87
  • Support Level
  • LGND $98.90
  • OLN $18.93
  • Resistance Level
  • LGND $103.17
  • OLN $20.69
  • Average True Range (ATR)
  • LGND 3.05
  • OLN 0.68
  • MACD
  • LGND -0.27
  • OLN -0.08
  • Stochastic Oscillator
  • LGND 31.94
  • OLN 9.61

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

Share on Social Networks: